We are live on
!
Find out more
Krystal Biotech
KRYS
KRYS
367 hedge funds and large institutions have $7.32B invested in Krystal Biotech in 2026 Q1 according to their latest regulatory filings, with 76 funds opening new positions, 137 increasing their positions, 105 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
155% more call options, than puts
Call options by funds: $81M | Put options by funds: $31.8M
117% more first-time investments, than exits
New positions opened: 76 | Existing positions closed: 35
30% more repeat investments, than reductions
Existing positions increased: 137 | Existing positions reduced: 105
25% more funds holding in top 10
Funds holding in top 10: 8 → 10 (+2)
10% more funds holding
Funds holding: 334 → 367 (+33)
4% more capital invested
Capital invested by funds: $7.02B → $7.32B (+$306M)
1.12% less ownership
Funds ownership: 98.16% → 97.04% (-1.1%)
Holders
367
Holders Change
+33
Holders Change %
+9.88%
% of All Funds
4.52%
Holding in Top 10
10
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+25%
% of All Funds
0.12%
New
76
Increased
137
Reduced
105
Closed
35
Calls
$81M
Puts
$31.8M
Net Calls
+$49.2M
Net Calls Change
+$17.9M
Top Buyers
| 1 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$56.4M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$50.9M |
| 3 |
First Trust Advisors
Wheaton,
Illinois
|
+$28M |
| 4 |
Raymond James Financial
St Petersburg,
Florida
|
+$21.2M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$19M |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$102M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$30.7M |
| 3 |
Goldman Sachs
New York
|
-$20.9M |
| 4 |
Corient Private Wealth
Miami,
Florida
|
-$19.5M |
| 5 |
Barclays
London,
United Kingdom
|
-$14.7M |
